Page 421 - Clinical Immunology_ Principles and Practice ( PDFDrive )

402 PARt tHREE Host Defenses to Infectious Agents

3. Moens E, Veldhoen M. Epithelial barrier biology: good fences make good 23. Yoshikai Y. The interaction of intestinal epithelial cells and intraepithelial
neighbours. Immunology 2012;135:1–8. lymphocytes in host defense. Immunol Res 1999;20:219–35.
4. Nestle FO, Di Meglio P, Qin JZ, et al. Skin immune sentinels in health 24. Gao Y, Williams AP. Role of innate T cells in anti-bacterial immunity.
and disease. Nat Rev Immunol 2009;9:679–91. Front Immunol 2015;6:302.
5. Eloe-Fadrosh EA, Rasko DA. The human microbiome: from symbiosis to 25. Gold MC, Lewinsohn DM. Co-dependents: MR1-restricted MAIT cells
pathogenesis. Annu Rev Med 2013;64:145–63. and their antimicrobial function. Nat Rev Microbiol 2013;11:14–19.
6. van Rensburg JJ, Lin H, Gao X, et al. The human skin microbiome 26. Napier RJ, Adams EJ, Gold MC, et al. The role of mucosal associated
associates with the outcome of and is influenced by bacterial infection. invariant T cells in antimicrobial immunity. Front Immunol 2015;6:344.
MBio 2015;6:e01315–15. 27. Mulks MH, Plaut AG. IgA protease production as a characteristic
7. Gallo RL, Hooper LV. Epithelial antimicrobial defence of the skin and distinguishing pathogenic from harmless neisseriaceae. N Engl J Med
intestine. Nat Rev Immunol 2012;12:503–16. 1978;299:973–6.
8. Kumar S, Ingle H, Prasad DV, et al. Recognition of bacterial infection by 28. Ribet D, Cossart P. How bacterial pathogens colonize their hosts and
innate immune sensors. Crit Rev Microbiol 2013;39:229–46. invade deeper tissues. Microbes Infect 2015;17:173–83.
9. Olive C. Pattern recognition receptors: sentinels in innate immunity and 29. Pan X, Yang Y, Zhang JR. Molecular basis of host specificity in human
targets of new vaccine adjuvants. Expert Rev Vaccines 2012;11:237–56. pathogenic bacteria. Emerg Microbes Infect 2014;3:e23.
10. Beutler B, Jiang Z, Georgel P, et al. Genetic analysis of host resistance: 30. Criss AK, Seifert HS. A bacterial siren song: intimate interactions between
Toll-like receptor signaling and immunity at large. Annu Rev Immunol Neisseria and neutrophils. Nat Rev Microbiol 2012;10:178–90.
2006;24:353–89. 31. Rouphael NG, Stephens DS. Neisseria meningitidis: biology, microbiology,
11. Quinn SR, O’Neill LA. A trio of microRNAs that control Toll-like and epidemiology. Methods Mol Biol 2012;799:1–20.
receptor signalling. Int Immunol 2011;23:421–5. 32. McNeil LK, Zagursky RJ, Lin SL, et al. Role of factor H binding protein in
12. Unkmeir A, Kämmerer U, Stade A, et al. Lipooligosaccharide and Neisseria meningitidis virulence and its potential as a vaccine candidate to
polysaccharide capsule: virulence factors of Neisseria meningitidis that broadly protect against meningococcal disease. Microbiol Mol Biol Rev
determine meningococcal interaction with human dendritic cells. Infect 2013;77:234–52.
Immun 2002;70:2454–62. 33. Mahalingam S, Lidbury BA. Antibody-dependent enhancement of
13. Ricklin D, Hajishengallis G, Yang K, et al. Complement: a key system for infection: bacteria do it too. Trends Immunol 2003;24:465–7.
immune surveillance and homeostasis. Nat Immunol 2010;11:785–97. 34. Roilides E, Simitsopoulou M, Katragkou A, et al. How Biofilms evade
14. Kawai T, Akira S. The role of pattern-recognition receptors in innate host defenses. Microbiol Spectr 2015;3(3).
immunity: update on Toll-like receptors. Nat Immunol 2010;11:373–84. 35. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. New
15. Papadopoulos A, Gorvel JP. Subversion of mouse dendritic cell subset Engl J Med 2002;348:138–50.
function by bacterial pathogens. Microb Pathog 2015;89:140–9. 36. Leentjens J, Kox M, van der Hoeven JG, et al. Immunotherapy for the
16. Sansonetti PJ, Phalipon A. M cells as ports of entry for enteroinvasive adjunctive treatment of sepsis: from immunosuppression to
pathogens: mechanisms of interaction, consequences for the disease immunostimulation. Time for a paradigm change? Am J Respir Crit Care
process. Semin Immunol 1999;11:193–203. Med 2013;187:1287–93.
17. Brinkmann V, Reichard U, Goosmann C, et al. Neutrophil extracellular 37. Needham BD, Trent MS. Fortifying the barrier: the impact of lipid A
traps kill bacteria. Science 2004;303:1532–5. remodelling on bacterial pathogenesis. Nat Rev Microbiol 2013;11:
18. Spits H, Artis D, Colonna M, et al. Innate lymphoid cells—a proposal for 467–81.
uniform nomenclature. Nat Rev Immunol 2013;13:145–9. 38. Kumar P, Chen K, Kolls JK. Th17 cell based vaccines in mucosal
19. Small CL, McCormick S, Gill N, et al. NK cells play a critical protective immunity. Curr Opin Immunol 2013;25:373–80.
role in host defense against acute extracellular Staphylococcus aureus 39. Lycke N. Recent progress in mucosal vaccine development: potential and
bacterial infection in the lung. J Immunol 2008;180:5558–68. limitations. Nat Rev Immunol 2012;12:592–605.
20. Fuchs A, Colonna M. Natural killer (NK) and NK-like cells at mucosal 40. Nakaya HI, Pulendran B. Vaccinology in the era of high-throughput
epithelia: mediators of antimicrobial defense and maintenance of tissue biology. Philos Trans R Soc Lond B Biol Sci 2015;370(1671).
integrity. Eur J Microbio Immunol (Bp) 2011;1:257–66. 41. Stephens DS, Hoffman LH, McGee ZA. Interaction of Neisseria
21. Cole J, Aberdein J, Jubrail J, et al. The role of macrophages in the innate Meningitidis with human nasopharyngeal mucosa—attachment and entry
immune response to Streptococcus pneumoniae and Staphylococcus into columnar epithelial cells. J Infect Dis 1983;148:369–76.
aureus: mechanisms and contrasts. Adv Microb Physiol 2014;65:125–202. 42. Singer M, Deutschman CS, Seymour CW, et al. The Third International
22. Peck A, Mellins ED. Precarious balance: Th17 cells in host defense. Infect Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA
Immun 2010;78:32–8. 2016;315:801–10.